Generics industry keeps up pressure on ICH
This article was originally published in SRA
Executive Summary
The international generic drug industry is refusing to take lying down the rejection by the International Conference on Harmonisation of its application for a place on the decision-making board of the key pharmaceutical standards and guidelines harmonisation initiative.